Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma

被引：15

作者：

Gu, Chao ^{[1
]}

Upchurch, Katherine ^{[2
]}

Mamaril-Davis, James ^{[1
]}

Wiest, Matthew ^{[1
,2
]}

Lanier, Bobby ^{[3
]}

Millard, Mark ^{[4
]}

Turner, Jacob ^{[5
]}

Joo, HyeMee ^{[1
,2
]}

Oh, SangKon ^{[1
,2
]}

机构：

[1] Mayo Clin, Dept Immunol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA

[2] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA

[3] North Texas Inst Clin Trials, Ft Worth, TX USA

[4] Baylor Univ, Med Ctr, Martha Foster Lung Care Ctr, Dallas, TX USA

[5] Stephen F Austin State Univ, Dept Math & Stat, Nacogdoches, TX 75962 USA

来源：

CLINICAL AND EXPERIMENTAL ALLERGY | 2020年 / 50卷 / 10期

关键词：

asthma; biomarkers; body mass index; immunoglobulin E; obesity; omalizumab;

D O I：

10.1111/cea.13696

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1196 / 1199

页数：4

共 50 条

[1] Omalizumab: Anti-IgE Therapy in Allergy
Matthias Volkmar Kopp
[J]. Current Allergy and Asthma Reports, 2011, 11 : 101 - 106
[2] Omalizumab (Xolair):: An anti-IgE antibody for asthma
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1163): : 67 - 68
[3] Omalizumab: Anti-IgE Therapy in Allergy
Kopp, Matthias Volkmar
[J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2011, 11 (02) : 101 - 106
[4] Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody
D'Amato, G
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (02) : 371 - 376
[5] Anti-IgE therapy for asthma
Demoly, P
Bousquet, J
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) : 1825 - 1827
[6] Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments
Pelaia, Girolamo
Vatrella, Alessandro
Busceti, Maria Teresa
Gallelli, Luca
Terracciano, Rosa
Maselli, Rosario
[J]. CURRENT DRUG TARGETS, 2015, 16 (02) : 171 - 178
[7] Anti-IgE antibody therapy for asthma
Barnes, PJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26): : 2006 - 2008
[8] Omalizumab - An effective anti-IgE treatment for allergic asthma and rhinitis
Casale, TB
[J]. DRUGS OF TODAY, 2004, 40 (04) : 367 - 376
[9] Omalizumab: A recombinant humanized anti-IgE antibody for allergic asthma
Ruffin, CG
Busch, BE
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (14) : 1449 - 1459
[10] Omalizumab, a novel anti-IgE therapy in allergic disorders
Babu, KS
Arshad, SH
Holgate, ST
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (06) : 1049 - 1058

← 1 2 3 4 5 →